Treatment of neuromyelitis optica spectrum disorders

KH Chan, CY Lee - International Journal of Molecular Sciences, 2021 - mdpi.com
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system
(CNS) inflammatory disorder that can lead to serious disability and mortality. Females are …

NMOSD acute attack: Understanding, treatment and innovative treatment prospect

X Ma, AG Kermode, X Hu, W Qiu - Journal of Neuroimmunology, 2020 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory
demyelinating disorders of the central nervous system that involves the optic nerve and …

Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus

N Braun, C Erley, R Klein, I Kötter… - Nephrology Dialysis …, 2000 - academic.oup.com
Background. Reduction of pathological autoantibodies and circulating immune complexes
can be useful in the treatment of autoimmune disease. Plasmapheresis has been shown to …

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig‐Therasorb)

M Jansen, S Schmaldienst, S Banyai… - British journal of …, 2001 - Wiley Online Library
Coagulation inhibitors may occur as alloantibodies in patients with congenital factor
deficiencies or as autoantibodies in patients with a previously normal coagulation. We …

Plasmapheresis for neurological disorders

A Schröder, RA Linker, R Gold - Expert review of neurotherapeutics, 2009 - Taylor & Francis
Apheresis is a general term that describes removal of abnormal blood constituents by
extracorporeal blood purification methods. To date, therapeutic plasma exchange (PE) is the …

Peptide based adsorbers for therapeutic immunoadsorption

W Rönspeck, R Brinckmann, R Egner… - Therapeutic …, 2003 - Wiley Online Library
Peptides as ligands for immunoadsorption exhibit several potentialadvantages over native
proteins. Two newly developed adsorbers arebased on peptides covalently coupled to …

Сорбенты для экстракорпорального удаления токсических веществ и молекул с нежелательной биологической активностью (обзор)

АС Морозов, ИВ Бессонов, АВ Нуждина… - Общая …, 2016 - cyberleninka.ru
В обзоре рассмотрены сорбенты и медицинские изделия на их основе, применяемые в
клинической практике для экстракорпоральной детоксикации с помощью процедуры …

Immunoadsorption, current status and future developments

N Braun, T Bosch - Expert opinion on investigational drugs, 2000 - Taylor & Francis
The association of abnormalities in the cellular and humoral immune system with various
autoimmune diseases provides the rationale for apheresis technologies. While …

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption

R Eming, J Rech, S Barth, JR Kalden, G Schuler… - Dermatology, 2006 - karger.com
Background: In pemphigus, loss of epidermal adhesion is induced by binding of circulating
autoantibodies to the desmosomal cadherins desmoglein 3 (Dsg3) in pemphigus vulgaris …

[HTML][HTML] Myasthenia gravis: Novel findings and perspectives on traditional to regenerative therapeutic interventions

EJC Huang, MH Wu, TJ Wang, TJ Huang, YR Li… - Aging and …, 2023 - ncbi.nlm.nih.gov
The prevalence of myasthenia gravis (MG), an autoimmune disorder, is increasing among
all subsets of the population leading to an elevated economic and social burden. The …